Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial. Borlaug BA, Zile MR, Kramer CM, Ye W, et al. J Am Coll Cardiol 2025;86:242-255.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Borlaug BA, Zile MR, Kramer CM, Ye W, et al. Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial. J Am Coll Cardiol 2025;86:242-255.
PMID: 40701669